SPAC1687.17c Antibody

What is SPAC1687.17c and why is it significant in research?

SPAC1687.17c is an uncharacterized derlin-like protein found in Schizosaccharomyces pombe (fission yeast) . This 190-amino acid protein belongs to the derlin family, which typically plays crucial roles in ER-associated degradation pathways. Its significance stems from its potential involvement in protein quality control mechanisms and membrane protein dynamics.

The protein's derlin-like classification suggests possible functions in the extraction and retrotranslocation of misfolded proteins from the endoplasmic reticulum, making it relevant for studies of cellular stress responses and protein homeostasis. Current research indicates it may interact with multiple cellular components, though these pathways remain incompletely characterized, presenting opportunities for novel discoveries in cellular biology.

What validation methods are essential for SPAC1687.17c antibodies?

Validating SPAC1687.17c antibodies requires a multi-faceted approach to ensure specificity and reliability in experimental applications. The following methodology is recommended:

• Western blot validation against recombinant protein: Use purified recombinant SPAC1687.17c protein as a positive control . The full-length recombinant protein (1-190 amino acids) with a His-tag is commercially available and provides an excellent reference standard.

• Knockout/deletion strain negative control: S. pombe deletion libraries contain SPAC1687.17c deletion strains that serve as critical negative controls . Compare antibody reactivity between wild-type and deletion strains to confirm specificity.

• Epitope competition assay: Pre-incubate the antibody with excess recombinant SPAC1687.17c protein before application to samples. Signal reduction confirms epitope-specific binding.

• Cross-reactivity assessment: Test the antibody against closely related derlin family proteins to ensure it doesn't cross-react with other family members.

• Immunoprecipitation followed by mass spectrometry: This confirms that the antibody pulls down the correct protein target along with its interacting partners.

What applications are suitable for SPAC1687.17c antibodies in S. pombe research?

SPAC1687.17c antibodies can be employed in numerous experimental applications:

Cellular localization studies: Immunofluorescence microscopy can track the protein's distribution, especially given its predicted membrane association as a derlin-like protein. This is particularly valuable for understanding subcellular dynamics during stress conditions.

Protein expression monitoring: Western blotting can quantify SPAC1687.17c expression levels across different growth conditions, cell cycle phases, or genetic backgrounds .

Interaction studies: Co-immunoprecipitation experiments identify binding partners, potentially revealing functional networks involving SPAC1687.17c. This approach is supported by evidence from search result indicating S. pombe proteins undergo regulated degradation through interaction with specific factors.

Chromatin association analysis: If SPAC1687.17c has any nuclear functions, chromatin immunoprecipitation followed by sequencing (ChIP-seq) could identify DNA binding regions.

FRET/FLIM studies: Combining antibody-based detection with fluorescence resonance energy transfer techniques can reveal proximity relationships with other cellular proteins.

How can SPAC1687.17c protein stability be assessed throughout the cell cycle?

Analyzing SPAC1687.17c stability across the cell cycle requires specialized approaches:

Cycloheximide chase assays: Similar to methods used for other S. pombe proteins, researchers can employ cycloheximide to inhibit new protein synthesis and track SPAC1687.17c degradation rates at different cell cycle stages . Cell synchronization techniques outlined in result should be adapted, including:

• HU arrest for early S-phase

• Temperature-sensitive cdc mutants for G1, G2, or M-phase arrests

• Nitrogen starvation for G0 arrest

Ubiquitination analysis: Evidence from other S. pombe proteins suggests ubiquitin-mediated degradation pathways are important . Researchers can:

• Transform cells with His6-ubiquitin or HA-ubiquitin plasmids

• Purify ubiquitinated proteins after proteasome inhibition

• Probe with SPAC1687.17c antibodies to detect ubiquitinated forms

Live-cell imaging: Creating GFP-tagged SPAC1687.17c constructs allows real-time monitoring of protein levels and localization through the cell cycle . Quantitative microscopy can track nuclear versus cytoplasmic distribution patterns at different cell cycle stages.

The table below summarizes cell cycle-specific approaches:

What methods can identify SPAC1687.17c interactions with the ubiquitin-proteasome system?

Based on knowledge of similar proteins in S. pombe, SPAC1687.17c likely interfaces with ubiquitin-proteasome machinery . The following methods can characterize these interactions:

Proteasome inhibitor studies: Treat cells with proteasome inhibitors (e.g., MG132) and monitor SPAC1687.17c accumulation using validated antibodies. This approach revealed degradation mechanisms for other fission yeast proteins described in result .

Ubiquitin ligase identification: Test SPAC1687.17c stability in E3 ligase mutants, particularly SCF complex components . Key mutants to examine include:

• Skp1 shut-off strains

• pof3 deletion mutants

• pop1/pop2 mutants

Degradation motif mapping: Generate truncation or point mutation series of SPAC1687.17c to identify sequences required for degradation, then use antibodies against the stable core to detect these constructs.

In vitro ubiquitination assays: Reconstitute the ubiquitination reaction using purified components and detect modified SPAC1687.17c using specific antibodies.

Mass spectrometry of immunoprecipitated protein: Identify ubiquitination sites and chain topologies on the native protein after immunoprecipitation with SPAC1687.17c antibodies.

How can transformation protocols be optimized for SPAC1687.17c functional studies?

When conducting genetic studies involving SPAC1687.17c, researchers must optimize transformation efficiency. Based on established S. pombe protocols , the following methodology is recommended:

Lithium acetate/PEG transformation system:

• Prepare standard reagents as described in search result :

  • Lithium acetate (102g LiOAc dihydrate per liter)

  • 44% PEG 3350 (440g PEG 3350 per liter)

  • Carrier DNA (herring sperm DNA, denatured)

• Pre-mix experimental plasmid (expressing SPAC1687.17c variants) with carrier DNA at standardized concentrations .

• Follow the high-efficiency transformation protocol that typically yields 1.0×10³ to 1.0×10⁴ transformants per microgram of plasmid DNA .

Working with deletion libraries:
When transforming SPAC1687.17c deletion strains for complementation studies, researchers should:

• Create working replicas from the original deletion library to preserve the master set .

• Use the 96-pin replicator tool for transferring strains from frozen stocks .

• Prepare glycerol stocks (50% glycerol) for long-term storage of transformed strains .

Transformation efficiency assessment:
Some deletion strains transform with significantly lower efficiencies . When working with SPAC1687.17c-related strains, researchers should:

• Include positive and negative control transformations in each batch

• Consider using increased DNA concentrations for difficult strains

• Optimize heat shock duration and temperature specifically for these strains

What techniques can resolve SPAC1687.17c membrane topology and cellular localization?

As a derlin-like protein, SPAC1687.17c likely contains multiple transmembrane domains requiring specialized approaches to determine topology:

Protease protection assays: Apply proteases to isolated membrane fractions with or without detergent permeabilization. Use domain-specific antibodies to identify protected versus exposed regions.

Split-GFP complementation: Fuse portions of GFP to different domains of SPAC1687.17c and express complementary GFP fragments in specific cellular compartments. Signal indicates the location of the tagged domain.

Fluorescence loss in photobleaching (FLIP): The methodology described in search result can be adapted to study SPAC1687.17c dynamics in living cells. This approach involves:

• Creating fluorescently-tagged SPAC1687.17c

• Repeatedly photobleaching a region of interest

• Measuring fluorescence loss throughout the cell

• Calculating diffusion rates and membrane association parameters

Immunoelectron microscopy: Use gold-labeled secondary antibodies against SPAC1687.17c primary antibodies for precise subcellular localization at the ultrastructural level, as mentioned in the electron microscopy methods from search result .

Biochemical fractionation: Separate cellular compartments and detect SPAC1687.17c distribution using specific antibodies. Compare different extraction conditions to determine membrane association strength.

How should epitope selection be approached for generating SPAC1687.17c antibodies?

Epitope selection is critical for generating effective SPAC1687.17c antibodies. The following strategy is recommended based on the protein's characteristics:

Analyze the primary sequence of SPAC1687.17c (190 amino acids) to identify regions with:

• High surface probability

• High antigenicity scores

• Low hydrophobicity (avoiding transmembrane regions)

• Low sequence conservation with other derlin family members

Consider functional domains: The derlin-like classification suggests multiple transmembrane domains. Antibodies against cytoplasmic loops or termini typically provide better accessibility in applications like immunofluorescence or immunoprecipitation.

Perform epitope mapping: For monoclonal antibodies, precisely characterize the epitope recognized. This information is crucial when interpreting results from different experimental conditions that might affect epitope accessibility.

Evaluate cross-species reactivity requirements: Determine if the antibody needs to recognize orthologs in other model organisms beyond S. pombe. If so, select conserved epitopes through multiple sequence alignment analysis.

What controls are essential when using SPAC1687.17c antibodies for immunoprecipitation?

Proper controls are critical for reliable immunoprecipitation experiments with SPAC1687.17c antibodies:

Input sample control: Analyze a portion of the starting material to confirm target protein presence and establish baseline abundance.

Negative controls:

• Immunoprecipitation from SPAC1687.17c deletion strains

• Use of isotype-matched irrelevant antibodies

• Peptide competition where specific epitope peptides block antibody binding

Positive controls:

• Immunoprecipitation of tagged SPAC1687.17c (His-tagged or GFP-tagged) using tag-specific antibodies

• Co-immunoprecipitation of known interacting partners (when identified)

Validation through reciprocal co-immunoprecipitation: Confirm interactions by performing immunoprecipitation in both directions (target ↔ interacting partner).

Mock treatment controls: Process samples without antibody addition to identify non-specific binding to beads or support matrices.

How can SPAC1687.17c antibodies be optimized for immunofluorescence microscopy?

Optimizing immunofluorescence protocols for SPAC1687.17c requires addressing several technical considerations:

Fixation method selection: Compare results from:

• Formaldehyde fixation (preserves structure but may mask epitopes)

• Methanol fixation (better penetration but potential protein extraction)

• Combined approaches (formaldehyde followed by methanol)

Cell wall digestion optimization: S. pombe cell walls require enzymatic digestion. Test different concentrations of zymolyase or lysing enzymes and digestion times to balance cell integrity with antibody accessibility.

Blocking and permeabilization: Determine optimal:

• Blocking reagents (BSA, normal serum, commercial blockers)

• Detergent concentrations (Triton X-100, Tween-20, saponin)

• Incubation times and temperatures

Antibody dilution series: Test primary antibody concentrations from 1:100 to 1:5000 to identify the optimal signal-to-noise ratio.

Signal amplification systems: For weak signals, consider:

• Tyramide signal amplification

• Quantum dot-conjugated secondary antibodies

• Multi-layer detection systems

Co-localization markers: Include antibodies against known organelle markers to define SPAC1687.17c's subcellular distribution, particularly ER/Golgi markers given its predicted derlin-like function.

What approaches can reveal SPAC1687.17c's function during cellular stress?

Given derlin proteins' typical roles in ER stress responses, several approaches can elucidate SPAC1687.17c's function during cellular stress:

Stress induction time course: Apply ER stressors (tunicamycin, DTT, thapsigargin) and monitor SPAC1687.17c levels/modification/localization using specific antibodies at multiple timepoints.

Genetic interaction screens: Transform SPAC1687.17c antibody-based constructs into deletion strain collections and screen for synthetic interactions with ER/protein quality control pathway components.

Transcriptional regulation analysis: Determine if SPAC1687.17c expression changes during stress by correlating protein levels (detected by antibodies) with mRNA abundance.

Post-translational modification profiling: Use 2D gel electrophoresis or mass spectrometry coupled with immunoblotting to identify stress-induced modifications of SPAC1687.17c.

Conditional degradation systems: Create auxin-inducible degron or temperature-sensitive SPAC1687.17c variants and monitor cellular consequences upon rapid protein depletion during stress conditions.

How can researchers address the challenges of detecting low-abundance SPAC1687.17c?

If SPAC1687.17c is expressed at low levels, several approaches can enhance detection sensitivity:

Sample enrichment strategies:

• Subcellular fractionation to concentrate membranes containing SPAC1687.17c

• Immunoprecipitation before immunoblotting

• Gradient centrifugation to isolate specific organelles

Signal amplification techniques:

• Enhanced chemiluminescence (ECL) substrates of varying sensitivity

• Tyramide signal amplification for immunohistochemistry

• Poly-HRP detection systems

Protein concentration methods:

• TCA precipitation

• Methanol-chloroform extraction

• Commercial protein concentration columns/kits

Expression enhancement approaches:

• Temporary overexpression from inducible promoters

• Growth condition optimization based on transcriptomic data

• Cell cycle synchronization to capture peak expression phases

Detection system optimization:

• Higher sensitivity detection instruments (e.g., cooled CCD cameras)

• Longer exposure times with low-background systems

• Computational image processing to enhance weak signals

What methodologies can characterize SPAC1687.17c protein-protein interactions?

Multiple complementary approaches can identify and validate SPAC1687.17c interaction partners:

Proximity-based approaches:

• BioID or TurboID fusion proteins to biotinylate proximal proteins

• APEX2 fusion for proximity-dependent biotinylation

• Split-protein complementation assays (PCA)

Affinity purification coupled with mass spectrometry:

• Traditional immunoprecipitation with SPAC1687.17c antibodies

• Tandem affinity purification (TAP) tags

• Multiple extraction conditions to capture different interaction states

Crosslinking-based methods:

• Chemical crosslinking coupled with mass spectrometry (XL-MS)

• Photo-activatable amino acid incorporation at specific positions

• In vivo formaldehyde crosslinking before immunoprecipitation

Membrane-specific interaction methods:

• Membrane yeast two-hybrid systems

• MYTH (membrane yeast two-hybrid)

• Split-ubiquitin assays optimized for membrane proteins

In vitro validation approaches:

• Surface plasmon resonance (SPR)

• Microscale thermophoresis (MST)

• In vitro pull-down assays with recombinant proteins

How can researchers overcome non-specific binding of SPAC1687.17c antibodies?

Non-specific binding is a common challenge with antibodies against less-characterized proteins like SPAC1687.17c. The following approaches can improve specificity:

Antibody purification strategies:

• Affinity purification against the immunizing antigen

• Negative selection against common cross-reactive proteins

• Pre-adsorption with cell lysates from deletion strains

Blocking optimization:

• Test different blocking agents (BSA, milk, commercial blockers)

• Increase blocking duration and concentration

• Include additional blocking components (non-ionic detergents, specific protein extracts)

Buffer modification:

• Adjust salt concentration (typically 150-500mM NaCl)

• Test different detergents and concentrations

• Add competing agents (e.g., polyvinylpyrrolidone, dextran sulfate)

Sample preparation optimization:

• Ensure complete protein denaturation for western blots

• Optimize fixation protocols for immunofluorescence

• Use freshly prepared samples to reduce denaturation/degradation artifacts

Validation with knockout controls:
Always compare antibody reactivity between wild-type and SPAC1687.17c deletion samples prepared identically .

What strategies can address antibody batch-to-batch variation in SPAC1687.17c detection?

Antibody consistency is essential for reproducible research. The following strategies can mitigate batch variation:

Comprehensive validation of each batch:

• Test new batches alongside previous validated batches

• Generate standard curves with recombinant protein

• Document batch-specific optimal working dilutions

Internal reference standards:

• Maintain aliquots of reference samples for comparative analysis

• Include positive control samples in each experiment

• Use loading controls for normalization

Epitope mapping:

• Precisely characterize the epitope(s) recognized by each batch

• Monitor for shifts in epitope preference

• Consider using multiple antibodies targeting different epitopes

Detailed record-keeping:

• Document lot numbers, validation results, and optimal conditions

• Create standardized protocols specific to each batch

• Maintain reference images for qualitative comparison

Antibody stabilization:

• Aliquot antibodies to minimize freeze-thaw cycles

• Add stabilizing proteins (BSA, gelatin)

• Store under optimal conditions (typically -20°C or -80°C with glycerol)